Q32 Bio (QTTB) Change in Accured Expenses (2017 - 2026)

Q32 Bio's Change in Accured Expenses history runs 10 years deep, the most recent figure standing at -$476000.0 for Q1 2026.

• In Q1 2026, Change in Accured Expenses rose 78.69% year-over-year to -$476000.0; the TTM figure through Mar 2026 stood at -$1.6 million (up 79.69% YoY), while the FY2025 annual figure was -$3.3 million, up 56.86% from the prior year.
• Change in Accured Expenses was -$476000.0 for Q1 2026 at Q32 Bio, down from $306000.0 in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $6.6 million in Q2 2022 to a low of -$5.0 million in Q1 2022.
• Historically, Change in Accured Expenses has averaged -$229470.6 across 5 years, with a median of -$889000.0 in 2025.
• The sharpest annual moves came in 2022 and 2024: Change in Accured Expenses jumped 172.56% in 2022, then slumped 194.19% in 2024.
• A 5-year view of Change in Accured Expenses shows it stood at $1.7 million in 2022, then jumped by 34.42% to $2.3 million in 2023, then sank by 143.37% to -$1.0 million in 2024, then jumped by 130.06% to $306000.0 in 2025, then tumbled by 255.56% to -$476000.0 in 2026.
• The last three Change in Accured Expenses figures came in at -$476000.0 (Q1 2026), $306000.0 (Q4 2025), and -$511000.0 (Q3 2025), per Business Quant data.